[Molecular tumor diagnostics as the driving force behind precision oncology]

Area of Science:

• Oncology
• Molecular Diagnostics
• Pathology

Context:

• Personalized oncology relies heavily on molecular pathological diagnostics.
• This field is crucial for both approved therapies and clinical trial patient selection.
• It also supports the generation of real-world data essential for drug development.

Purpose:

• To highlight the central role of molecular pathological diagnostics in personalized cancer care.
• To emphasize its importance in clinical studies and real-world data generation.
• To outline future directions in scalable and adaptive diagnostic strategies.

Summary:

• Molecular pathological diagnostics is integral to personalized oncology, guiding treatment decisions for individual patients and clinical studies.
• It facilitates the identification of therapeutic targets and biomarkers, and supports real-world data collection for drug development.
• Advancements in scalable diagnostics are needed to interpret complex datasets and develop adaptive strategies for dynamic cancer diseases.

Impact:

• Enhances precision in cancer treatment through tailored therapies.
• Improves patient stratification for clinical trials and targeted therapies.
• Accelerates drug development by leveraging real-world data and advanced diagnostics.